Probiotics for prevention of nosocomial infections: Efficacy and adverse effects

Current Opinion in Critical Care

Volumn 17, Issue 5, 2011, Pages 487-492

  Oudhuis, Guy J ^a,c   Bergmans, Dennis C J J ^b   Verbon, Annelies ^a,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

critical care; infection prevention; lactic acid bacteria; safety

Indexed keywords

PROBIOTIC AGENT;

ABDOMINAL DISEASE; ABDOMINAL SURGERY; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; HOSPITAL INFECTION; HUMAN; PANCREATITIS; POSTOPERATIVE BACTERIAL INFECTION; POSTOPERATIVE INFECTION; REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

CROSS INFECTION; DIGESTIVE SYSTEM DISEASES; HUMANS; INTENSIVE CARE; PNEUMONIA, VENTILATOR-ASSOCIATED; PROBIOTICS;

EID: 80052706576     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e32834a4bab     Document Type: Review

References (69)

1. Lilly DM, Stillwell RH. Probiotics: growth-promoting factors produced by microorganisms. Science 1965; 147:747-748.
2. Pitsouni E, Alexiou V, Saridakis V, et al. Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2009; 65:561-570.
3. Zhang MM, Cheng JQ, Lu YR, et al. Use of pre, pro- and synbiotics in patients with acute pancreatitis: a meta-analysis. World J Gastroenterol 2010; 16:3970-3978.
4. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med 2010; 38:954-962.
5. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebocontrolled trial. Lancet 2008; 371:651-659.
6. Knight DJ, Gardiner D, Banks A, et al. Effect of synbiotic therapy on the incidence of ventilator-associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Intensive Care Med 2009; 35:854-861.
7. Barraud D, Blard C, Hein F, et al. Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med 2010; 36:1540-1547.
8. Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010; 182:1058-1064.
9. Liu Z, Qin H, Yang Z, et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery: a double-blind study. Aliment Pharmacol Ther 2011; 33:50-63.
10. Oudhuis GJ, Bergmans DC, Dormans T, et al. Probiotics versus antibiotic decontamination of the digestive tract: infection and mortality. Intensive Care Med 2011; 37:110-117.
11. Joint FAO/WHO expert consultation. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO/WHO; 2001. http://www.who.int/foodsafety/publications/fs-management/ probiotics/en/. [Accessed 24 April 2011]
12. Joint FAO/WHO working group meeting. Guidelines for the evaluation of probiotics in food. FAO/WHO; 2002. http://www.who.int/foodsafety/publications/ fs-management/probiotics2/en/. [Accessed 24 April 2011]
13. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125:1401-1412.
14. Wang X, Brown IL, Evans AJ, Conway PL. The protective effects of high amylose maize (Amylomaize) starch granules on the survival of Bifidobacterium spp. in the mouse intestinal tract. J Appl Microbiol 1999; 87:631-639. (Pubitemid 30038463)
15. Bengmark S. Pre, pro- and synbiotics. Curr Opin Clin Nutr Metab Care 2001;4:571-579.
16. Watkinson PJ, Barber VS, Dark P, Young JD. The use of pre pro- and synbiotics in adult intensive care unit patients: systematic review. Clin Nutr 2007; 26:182-192. (Pubitemid 46504825)
17. Klarin B, Johansson ML, Molin G, et al. Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit Care 2005; 9:R285-R293.
18. Isakow W, Morrow LE, Kollef MH. Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. Chest 2007; 132:286-294. (Pubitemid 47068233)
19. Madsen K. Probiotics in critically ill patients. J Clin Gastroenterol 2008; 42 (Suppl 3 Pt 1):S116-S118.
20. Adlerberth I, Ahrne S, Johansson ML, et al. A mannose-specific adherence mechanism in Lactobacillus plantarum conferring binding to the human colonic cell line Ht-29. Appl Environ Microbiol 1996; 62:2244-2251. (Pubitemid 26231184)
21. Mack DR, Michail S, Wei S, et al. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276:G941-G950. (Pubitemid 29214108)
22. Haskard C, Binnion C, Ahokas J. Factors affecting the sequestration of aflatoxin by Lactobacillus rhamnosus strain GG. Chem Biol Interact 2000; 128:39-49.
23. Oatley JT, Rarick MD, Ji GE, Linz JE. Binding of aflatoxin B1 to bifidobacteria in vitro. J Food Prot 2000; 63:1133-1136.
24. Dai D, Walker WA. Protective nutrients and bacterial colonization in the immature human gut. Adv Pediatr 1999; 46:353-382.
25. Aiba Y, Suzuki N, Kabir AM, et al. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol 1998; 93:2097-2101. (Pubitemid 29076857)
26. Eckmann L. Innate immunity and mucosal bacterial interactions in the intestine. Curr Opin Gastroenterol 2004; 20:82-88. (Pubitemid 38297393)
27. Gionchetti P, Lammers KM, Rizzello F, Campieri M. Probiotics and barrier function in colitis. Gut 2005; 54:898-900. (Pubitemid 40873896)
28. Akisu M, Baka M, Yalaz M, et al. Supplementation with Saccharomyces boulardii ameliorates hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. Eur J Pediatr Surg 2003; 13:319-323. (Pubitemid 37462367)
29. Pulverer G, Ko HL, Roszkowski W, et al. Digestive tract microflora liberates low molecular weight peptides with immunotriggering activity. Zentralbl Bakteriol 1990; 272:318-327. (Pubitemid 20128776)
30. HatcherGE, Lambrecht RS. Augmentation of macrophage phagocytic activity by cell-free extracts of selected lactic acid-producing bacteria. J Dairy Sci 1993; 76:2485-2492.
31. Qamar A, Aboudola S, Warny M, et al. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice. Infect Immun 2001; 69:2762-2765. (Pubitemid 32239759)
32. Macpherson AJ, Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004; 303:1662-1665. (Pubitemid 38338323)
33. Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004; 126:520-528. (Pubitemid 38182309)
34. Sheih YH, Chiang BL, Wang LH, et al. Systemic immunity-enhancing effects in healthy subjects following dietary consumption of the lactic acid bacterium Lactobacillus rhamnosus Hn001. J Am Coll Nutr 2001; 20:149-156.
35. Niers LE, Timmerman HM, Rijkers GT, et al. Identification of strong interleukin- 10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin Exp Allergy 2005; 35:1481-1489.
36. Hart AL, Lammers K, Brigidi P, et al. Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut 2004; 53:1602-1609. (Pubitemid 39434103)
37. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 1995; 20:333-338.
38. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101:812-822.
39. Masood MI, Qadir MI, Shirazi JH, Khan IU. Beneficial effects of lactic acid bacteria on human beings. Crit Rev Microbiol 2011; 37:91-98.
40. Kruis W. Review article: antibiotics and probiotics in inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20 (Suppl 4):75-78. (Pubitemid 39319251)
41. Viljanen M, Savilahti E, Haahtela T, et al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy 2005; 60:494-500. (Pubitemid 40332976)
42. Rayes N, Hansen S, Seehofer D, et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 2002; 18:609-615. (Pubitemid 34687100)
43. Rayes N, Seehofer D, Hansen S, et al. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002; 74:123-127.
44. Olah A, Belagyi T, Issekutz A, et al. Randomized clinical trial of specific Lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002; 89:1103-1107. (Pubitemid 34989215)
45. Rayes N, Seehofer D, Theruvath T, et al. Supply of pre and probiotics reduces bacterial infection rates after liver transplantation: a randomized, double-blind trial. Am J Transplant 2005; 5:125-130. (Pubitemid 40095136)
46. Rayes N, Seehofer D, Theruvath T, et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg 2007; 246:36-41. (Pubitemid 47012204)
47. Kanazawa H, Nagino M, Kamiya S, et al. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 2005; 390:104-113. (Pubitemid 40487433)
48. Nomura T, Tsuchiya Y, Nashimoto A, et al. Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepatogastroenterology 2007; 54:661-663. (Pubitemid 46903696)
49. McNaught CE, Woodcock NP, MacFie J, Mitchell CJ. A prospective randomized study of the probiotic Lactobacillus plantarum 299v on indices of gut barrier function in elective surgical patients. Gut 2002; 51:827-831. (Pubitemid 35408604)
50. Anderson AD, McNaught CE, Jain PK, MacFie J. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 2004; 53:241-245. (Pubitemid 38125512)
51. Reddy BS, Macfie J, Gatt M, et al. Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 2007; 94:546-554. (Pubitemid 46732236)
52. Rayes N, Seehofer D, Neuhaus P. Prebiotics, probiotics, synbiotics in surgery: are they only trendy, truly effective or even dangerous? Langenbecks Arch Surg 2009; 394:547-555.
53. Olah A, Belagyi T, Poto L, et al. Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology 2007; 54:590-594. (Pubitemid 46724735)
54. Jain PK, McNaught CE, Anderson AD, et al. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr 2004; 23:467-475. (Pubitemid 39107024)
55. McNaught C, Woodcock N, Anderson A, MacFie J. A prospective randomized trial of probiotics in critically ill patients. Clin Nutr 2005; 24:211-219. (Pubitemid 40392804)
56. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, et al. Benefits of a synbiotic formula (Synbiotic 2000forte) in critically ill trauma patients: early results of a randomized controlled trial. World J Surg 2006; 30:1848-1855. (Pubitemid 44454998)
57. Spindler-Vesel A, Bengmark S, Vovk I, et al. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. JPEN J Parenter Enteral Nutr 2007; 31:119-126.
58. Forestier C, Guelon D, Cluytens V, et al. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebocontrolled pilot study in intensive care unit patients. Crit Care 2008; 12:R69.
59. Klarin B, Molin G, Jeppsson B, Larsson A. Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: a randomised controlled open pilot study. Crit Care 2008; 12:R136.
60. McNabb B, Isakow W. Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions. CurrOpin Pulm Med 2008; 14:168-175. (Pubitemid 351572317)
61. Koretz RL. Probiotics, critical illness, and methodologic bias. Nutr Clin Pract 2009; 24:45-49.
62. Bengmark S. Synbiotics to strengthen gut barrier function and reduce morbidity in critically ill patients. Clin Nutr 2004; 23:441-445. (Pubitemid 39107021)
63. Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii. Support Care Cancer 2000; 8:504-505.
64. Land MH, Rouster-Stevens K, Woods CR, et al. Lactobacillus sepsis associated with probiotic therapy. Pediatrics 2005; 115:178-181. (Pubitemid 43046298)
65. Sullivan A, Nord CE. Probiotic Lactobacilli and bacteraemia in Stockholm. Scand J Infect Dis 2006; 38:327-331. (Pubitemid 43832396)
66. De Groote MA, Frank DN, Dowell E, et al. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005; 24:278-280. (Pubitemid 40365870)
67. Hennequin C, Kauffmann-Lacroix C, Jobert A, et al. Possible role of catheters in Saccharomyces boulardii fungemia. Eur J Clin Microbiol Infect Dis 2000; 19:16-20. (Pubitemid 30093376)
68. Salminen MK, Tynkkynen S, Rautelin H, et al. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002; 35:1155-1160. (Pubitemid 35305862)
69. Besselink MG, van Santvoort HC, Renooij W, et al. Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Ann Surg 2009; 250:712-719.